We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 4,653

Does the NAD’s Capillus Decision Baldly Contradict the FDA?
  • Kelley Drye & Warren LLP
  • USA
  • September 20 2017

On September 12, the NAD released its decision in its review of the Capillus82 hair growth device (Case 6107). This case is unusual in that it


Court Blocks San Francisco Law Requiring Warnings on Soft Drink Ads
  • Keller and Heckman LLP
  • USA
  • September 20 2017

As previously covered on this blog, the City of San Francisco passed legislation in June 2015 that required health warnings to be placed on


Lawsuit Over FDA Delaying Menu Labeling Rule on Hold for Now
  • Keller and Heckman LLP
  • USA
  • September 19 2017

As previously reported on this blog, on June 7, 2017, two nongovernment organizations (NGOs)the Center for Science in the Public Interest and the


Checking Out the B-Side
  • Dechert LLP
  • USA
  • September 19 2017

Search for Medtronic on this blog and you're going to find preemption cases. Lots of preemption cases. Mostly preemption victories for the defense. An


Litigation Leading Science
  • Bradley Arant Boult Cummings LLP
  • USA
  • September 19 2017

Parties and courts in complex product liability cases often wrestle with whether the current state of science with respect to the particular product


When Plaintiff Conduct Matters
  • Reed Smith LLP
  • USA
  • September 18 2017

We previously addressed the in pari delicto doctrine, whereby a plaintiff injured in the course of his or her criminal conduct cannot recover for


Medical Monitoring Class Certification Fails
  • Reed Smith LLP
  • USA
  • September 15 2017

Normally, when we think of decisions relating to medical monitoring, the issue is whether a state will recognize medical monitoring for uninjured


Northern District of New York (Quickly!) Holds that the MDA Expressly Preempts Essure Suit
  • Reed Smith LLP
  • USA
  • September 14 2017

A couple of weeks ago, our co-blogger, Mr. McConnell, published a post on the benefits of brevity. That post sprang from an argument before the JPML


The Third Circuit Fosamax Preemption Error Has Got to Go
  • Reed Smith LLP
  • USA
  • September 13 2017

Last week we were going through the regulatory record of a drug that is now the subject of mass tort litigation. This effort is central to assembling


Natural Supplement Maker Sues Rival Under Lanham Act
  • Baker & Hostetler LLP
  • USA
  • September 12 2017

SARMs (selective androgen receptor modulators) are synthetic drugs designed to have effects similar to those of illegal anabolic steroids, but with a